Venture Partner
Monal Mehta, PH.D.
Background
Monal is a Venture Partner in Versant’s NYC office where she focuses on investing in and working with early stage companies. Monal was a Managing Director at Avidity Partners’ Private Fund, leading and sourcing investment opportunities from Series A through public investments, with several successful exits. She was previously on the boards of 858 Therapeutics, Endeavor Biomedicines, MBrace Therapeutics, Prellis Biologics, and Quanta Therapeutics.
History
Prior to starting her career in healthcare investing, Monal worked in business development at Pfizer and was also a consultant in Navigant’s Life Sciences practice.
She earned a Ph.D. in Cancer Biology from the University of Medicine and Dentistry of New Jersey where she focused on mechanisms of radiation resistance and DNA damage repair.